Show simple item record

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorPicchio, Camila Andrea
dc.contributor.authorNomah, Daniel K.
dc.contributor.authorAraujo, Silvia G.
dc.contributor.authorRando Segura, Ariadna
dc.contributor.authorFernández, Emma
dc.contributor.authorButi Ferret, Maria
dc.contributor.authorRodríguez Frias, Francisco
dc.date.accessioned2022-05-02T13:05:09Z
dc.date.available2022-05-02T13:05:09Z
dc.date.issued2021-08-25
dc.identifier.citationPicchio CA, Nomah DK, Araujo SG, Rando-Segura A, Fernández E, Buti M, et al. A novel model of care for simplified testing of HBV in African communities during the COVID-19 pandemic in Spain. Sci Rep. 2021 Aug 25;11:17063.
dc.identifier.issn2045-2322
dc.identifier.urihttp://hdl.handle.net/11351/7447
dc.descriptionEpidemiology; Health services; Viral hepatitis
dc.description.abstractChronic hepatitis B virus (HBV) infection is a major public health threat for migrant populations in Spain and efforts to scale up testing are needed to reach the WHO elimination targets. The Hepatitis B Virus Community Screening and Vaccination in Africans (HBV-COMSAVA) study aims to use point-of-care testing and simplified diagnostic tools to identify, link to care, or vaccinate African migrants in Barcelona during the COVID-19 pandemic. From 21/11/20 to 03/07/2021, 314 study participants were offered HBV screening in a community clinic. Rapid tests for HBsAg screening were used and blood samples were collected with plasma separation cards. Patients received results and were offered: linkage to specialist care; post-test counselling; or HBV vaccination in situ. Sociodemographic and clinical history were collected and descriptive statistics were utilized. 274 patients were included and 210 (76.6%) returned to receive results. The HBsAg prevalence was 9.9% and 33.2% of people had evidence of past resolved infection. Overall, 133 required vaccination, followed by post-test counselling (n = 114), and linkage to a specialist (n = 27). Despite the COVID-19 pandemic, by employing a community-based model of care utilizing novel simplified diagnostic tools, HBV-COMSAVA demonstrated that it was possible to diagnose, link to care, and vaccinate African migrants in community-based settings.
dc.language.isoeng
dc.publisherNature Research
dc.relation.ispartofseriesScientific Reports;11
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectEmigració i immigració
dc.subjectHepatitis B - Diagnòstic
dc.subjectQuímica clínica
dc.subject.meshPoint-of-Care Testing
dc.subject.meshHepatitis B, Chronic
dc.subject.mesh/diagnosis
dc.subject.meshEmigrants and Immigrants
dc.titleA novel model of care for simplified testing of HBV in African communities during the COVID-19 pandemic in Spain
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1038/s41598-021-96350-3
dc.subject.decsanálisis de diagnóstico inmediato
dc.subject.decshepatitis B crónica
dc.subject.decs/diagnóstico
dc.subject.decsemigrantes e inmigrantes
dc.relation.publishversionhttps://doi.org/10.1038/s41598-021-96350-3
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Picchio CA, Araujo SG, Fernández E] Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain. [Nomah DK] Department of Health, Center for Epidemiological Studies on Sexually Transmitted Infections and HIV/AIDS in Catalonia (CEEISCAT), Generalitat of Catalonia, Badalona, Spain. [Rando-Segura A] Unitat de Patologia Hepàtica, Servei de Bioquímica i Microbiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Buti M] CIBER Hepatic and Digestive Diseases (CIBERehd), Instituto Carlos III, Madrid, Spain. Unitat del Fetge, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Rodríguez-Frías F] Unitat de Patologia Hepàtica, Servei de Bioquímica i Microbiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. CIBER Hepatic and Digestive Diseases (CIBERehd), Instituto Carlos III, Madrid, Spain
dc.identifier.pmid34433852
dc.identifier.wos000688551400042
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record